Top Stock Research Reports For AbbVie, Accenture, TOTAL & Others
Zacks Investment Research | Feb 11, 2020 01:09AM ET
Tuesday, February 11, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie (ABBV), Accenture (NYSE:ACN) (ACN) and TOTAL (TOT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, Amazon is riding on expanding quick delivery services via Prime which are aiding its retail position. Also, strengthening cloud offerings are bolstering AWS adoption rate.
The Zacks analyst expects Enbridge to generate stable cash flow from multi-billion-dollar worth of natural gas and oil transportation project backlog. However, its debt burden is concerning.
Per the Zacks analyst, Intuit is benefiting from frequent product refreshes, which help it to gain customers.
The Zacks analyst is impressed by the company's measures to reward shareholders through dividends and repurchases.
Per the Zacks analysts, Ross Stores witnesses robust comps driven by strength across categories, except ladies apparel.
Per the Zacks analyst disciplined investments in infrastructure projects and focus on renewable expansion will strengthen Xcel Energy's existing operations.
The Zacks analyst believes that the Ipreo acquisition boosts IHS Markit's financial services segment. However, high acquisition related costs remain a headwind.
Per the Zacks analyst, Amazon is riding on expanding quick delivery services via Prime which are aiding its retail position. Also, strengthening cloud offerings are bolstering AWS adoption rate.
The Zacks analyst expects Enbridge to generate stable cash flow from multi-billion-dollar worth of natural gas and oil transportation project backlog. However, its debt burden is concerning.
Per the Zacks analyst, Intuit is benefiting from frequent product refreshes, which help it to gain customers.
The Zacks analyst is impressed by the company's measures to reward shareholders through dividends and repurchases.
Per the Zacks analysts, Ross Stores witnesses robust comps driven by strength across categories, except ladies apparel.
Per the Zacks analyst disciplined investments in infrastructure projects and focus on renewable expansion will strengthen Xcel Energy's existing operations.
The Zacks analyst believes that the Ipreo acquisition boosts IHS Markit's financial services segment. However, high acquisition related costs remain a headwind.
New Upgrades/h6
Per the Zacks analyst, its Commercial Lines Insurance segment has been consistently performing well on the back of several strategic initiatives and price increases, contributing to overall growth.
Per the Zacks Analyst, Increased contract wins for its cost-effective defense solutions from the Pentagon drives the company's growth and bolster its backlog.
Per the Zacks analyst, FormFactor benefits from strength in both Foundry & Logic probe cards, new design releases and solid execution. Also, DRAM demand is likely to remain solid in the long term.
Per the Zacks analyst, its Commercial Lines Insurance segment has been consistently performing well on the back of several strategic initiatives and price increases, contributing to overall growth.
Per the Zacks Analyst, Increased contract wins for its cost-effective defense solutions from the Pentagon drives the company's growth and bolster its backlog.
Per the Zacks analyst, FormFactor benefits from strength in both Foundry & Logic probe cards, new design releases and solid execution. Also, DRAM demand is likely to remain solid in the long term.
New Downgrades/h6
Per the Zacks analyst, stiff competition for HIV franchise hurt Gilead. Additionally, the uptake of Yescarta hasn't been impressive and the treatment faces stiff competition from Kymriah.
Tight oil exploration and production (E&P) capital spending will hurt demand for Baker Hughes' oilfield services in North America, agrees the Zacks analyst.
Per the Zacks analyst, soft trend in the Mobile market, with particular weakness in the premium portion of the Android ecosystem, is acting as a major headwind for Knowles' audio business.
Per the Zacks analyst, stiff competition for HIV franchise hurt Gilead. Additionally, the uptake of Yescarta hasn't been impressive and the treatment faces stiff competition from Kymriah.
Tight oil exploration and production (E&P) capital spending will hurt demand for Baker Hughes' oilfield services in North America, agrees the Zacks analyst.
Per the Zacks analyst, soft trend in the Mobile market, with particular weakness in the premium portion of the Android ecosystem, is acting as a major headwind for Knowles' audio business.
Get The News You Want
undefined Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.